CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada

Clin Mol Hepatol. 2021;27(3):413-424. Published online 2020 December 3 DOI: https://doi.org/10.3350/cmh.2020.0187

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada

Clinical and Molecular Hepatology. 2021;27(3):413-424

Link1

Link2 Link3

Current and Future Anti-Fibrotic Therapies for Chronic Liver Disease

Don C. Rockey

Clinics in Liver Disease. 2008;12(4):939-962

Link1 Link2

Drug treatments of the future in fibrotic lung disease

Athol U. Wells

Drugs for the Treatment of Respiratory Diseases. 2003;336-360

Link1

New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases

Sara Lemoinne, Scott L Friedman

Current Opinion in Pharmacology. 2019;49:60-70

Link1 Link2

The role of the gut microbiome in chronic liver diseases: Present insights and future outlook

Lu Jiang, Jian-Gao Fan

Hepatobiliary & Pancreatic Diseases International. 2023;

Link1 Link2

Promising New Treatments for Chronic Pain

Robert W. Baloh

Sciatica and Chronic Pain. 2018;109-120

Link1

Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases

Olav A. Gressner, Axel M. Gressner

Liver International. 2008;28(8):1065-1079

Link1 Link2

Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles Application in Acute and Chronic Inflammatory Liver Diseases: Emphasizing on the Anti-Fibrotic and Immunomodulatory Mechanisms

Ali Hazrati, Kosar Malekpour, Sara Soudi, Seyed Mahmoud Hashemi

Frontiers in Immunology. 2022;13:

Link1

Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection

Norberto Perico, Ariela Benigni, Giuseppe Remuzzi

Nature Reviews Drug Discovery. 2008;7(11):936-953

Link1

Link2 Link3

The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis

Berna Karakoyun

Liver Cirrhosis - Update and Current Challenges. 2017;

Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.